FFECT OF LIRAGLUTIDE ON CARDIOVASCULAR RISK FACTORS AND FUNCTION
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 3
Abstract
Cardiovascular disease is the major cause of death in diabetes. This results from a cluster of risk factors, including high glucose, obesity, hypertension and dyslipidaemia. Liraglutide is the first native GLP-1 analogue and represents a breakthrough approach in type 2 diabetes treatment. Previous data from the LEAD™ programme have shown liraglutide to be a potent glucose regulator, but also to induce weight loss, lower blood pressure, and potentially show improvements in lipid levels, amongst other markers of cardiovascular risk. GLP-1 has also been shown to have an effect on the renal system, as well as the vascular system. Other cardio-protective effects of GLP-1 were proved in animal models: improves cardiac function in heart failure, functional recovery following myocardial ischemia, endothelium dysfunction, increases myocardial glucose uptake and reduces infarct size. Cardiovascular safety of liraglutide was assessed using existing clinical data. The incidence ratio for adjudicated broad/serious major adverse cardiovascular events (MACE) associated with liraglutide was 0.73 (95% CI 0.38–1.41) versus all comparator drugs, within cardiovascular safety limits defined by the United States Food & Drug Administration.
Authors and Affiliations
Maria Mota, Emiliana Mocan, Sorina Botescu
Keywords
Related Articles
- EP ID EP113933
- DOI -
- Views 104
- Downloads 0
NOCTURNAL HYPERTENSION AND SPECIAL - PERIOD HYPERTENSION IN TYPE 1 DIABETES MELLITUS
Background: One of the unique aspects of continuous ambulatory arterial-tension monitoring is the ability of recording the diurnal variations. The patients suffering from Type 1 Diabetes Mellitus (T1DM) may present...
Association Of N Acetyl Transferase 2 Gene Polymorphisms With Type 1 Diabetes
Epidemiological studies suggested an association between dietary nitrates/nitrites and Type 1 diabetes (T1DM), association mediated by the N Acetyl Transferases. Early data indicated a role of N Acetyl Transferase 2 (NAT...
THE RESUMPTION OF MENSES TROUGH REDUCTION OF WEIGHT AND TREATMENT WITH METFORMIN TO A YOUNG GIRL WITH THE POLYCYSTIC OVARY SYNDROME
Objectives: We aimed to evaluate the effect of reducing body weight by optimization of lifestyle and the utility of metformin association to a young obese woman with polycystic ovary syndrome (PCOS). Material and Method:...
SLEEVE GASTRECTOMY TO CORRECT OBESITY AND ASSOCIATED CO-MORBIDITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Obesity has become a serious health problem and it is a major risk factor for the development of insulin resistance and type 2 diabetes mellitus (T2DM). Laparoscopic sleeve gastrectomy (LSG) has revealed to be effective...
Epidemiological Characteristics Of Diabetes Mellitus And Impaired Glucose Regulation In The Population Of Hunedoara County
There are few studies that have examined the prevalence of type 2 diabetes mellitus (DM) in Romania. In the study described in this paper we evaluated the utility of HbA1C in the screening and diagnosis of type 2 DM, in...